Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Asia Pacific Intelligence

Blue Sky reports 48% growth in revenue

Thursday, September 05, 2013

Australia's only listed alternative investments firm Blue Sky Alternative Investments has reported a $3.59m net profit after tax and 48% growth in revenue for the full year ending 30 June 2013.

In August 2013, Blue Sky completed a successful private share placement, raising an additional $6.83m, which will be used to co-invest in Blue Sky managed funds.

In the last 12 months, the company increased its assets under management (AUM) from approximately $200m to $350m.

Founder and managing director Mark Sowerby said the 2013 financial year had seen Blue Sky reach several milestones and build the foundation for its next level of growth.

"We have expanded our investment teams, infrastructure, systems and distribution channels while maintaining performance across the group's funds at better than 15% per annum compounding since inception," he said.

"In a low growth economic environment, investors continue to seek out new ideas, absolute performance and alignment. This is driving a greater proportion of global savings to alternative assets."

"Our offerings across private equity, private real estate, hedge funds and real assets (currently water and water infrastructure) uniquely position us to participate in these global trends," Mr Sowerby said.

Blue Sky was listed on the Australian Securities Exchange in January 2012. Established in 2006, Blue Sky has generated strong returns uncorrelated with Australian listed equity markets. The firm has offices in Brisbane, Sydney, Adelaide and New York, a team of over 40 and a broad investor base including institutional, wholesale and retail clients.

Alternative assets include direct investment in private equity, real estate, infrastructure, hedge funds and other real assets.

 
This article was published in Opalesque's Asia Pacific Intelligence our monthly research update on alternative investments in the Asia-Pacific region.
Asia Pacific Intelligence
Asia Pacific Intelligence
Asia Pacific Intelligence
Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for